The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Meridian Bioscience

  • VIVO
  • NASDAQ
  • Consumer Products
  • Latest 21.63
  • Currency US$
  • Change -0.22
  • Percent Change -1.007 %
  • Volume 31,233
  • Tue May 21, 2013 12:19 PM EDT NASDAQ data delayed 15 minutes.
Average recommendation
10 Analysts Reporting (Nov 07, 2012)
Strong Buy
Buy
Hold
Underperform
Sell
Change over time
Analyst rating breakdown
  Latest 4 weeks ago 2 months ago 3 months ago Last Year
Strong Buy 2 3 3 3 3
Buy 1 1 1 1 1
Hold 5 4 5 5 5
Underperform 0 0 0 0 0
Sell 2 2 2 2 2

As of Tue May 21, 2013 12:37 PM EDT
The consensus recommendation is the average buy, sell or hold rating for a company, based on a survey of brokerage equity analysts by Zacks Investment Research. We update the ratings daily.

Earnings & Estimates

Short Term
    Q4/10 Q1/11 Q2/11 Q3/11 Q4/11 Q1/12 Q2/12 Q3/12 Q3/13 Q4/13  

Actual quarterly earnings for the past eight quarters and estimated for the next two quarters
Estimated EPS ($)   0.18 0.19 0.20 0.21 0.19 0.19 0.20 0.22 0.22 0.23  
Actual EPS   0.15 0.15 0.20 0.17 0.18 0.17 0.23 0.21 -- --  
Surprise (%)   -16.7 -21.0 -- -19.0 -5.3 -10.5 15.0 -4.6 -- --  
Est. % Chg from Prior Year   -0.3 -0.3 0.3 -- 0.2 0.1 0.2 0.2 3.8 7.6  
{#} Analysts   8 7 9 11 11 10 10 7 5 5  
Date of Earnings   Nov 11 Jan 20 Apr 21 Jul 21 Nov 10 Jan 25 Apr 26 Jul 26 Jul 25 Nov 07  

Data provided by Zacks Investment Research.

Long Term
    2013 2014  

Estimated annual earnings for the next
two years
Estimated EPS ($)   0.89 1.02  
Actual EPS   0.82 0.89  
Surprise (%)   -- --  
Est. % Chg from Prior Year   8.7 13.9  
{#} Analysts   7 4  
Date of Earnings   -- --  

Trends & Revisions

Earnings Per Share Trend
  Current 7-Days Ago 30-Days Ago 60-Days Ago 90-Days Ago
  Mean Mean Mean Mean Mean
Current Quarter (ends Jun 2013) 0.22 0.22 0.22 0.22 0.22
Next Quarter (ends Sep 2013) 0.23 0.23 0.23 0.23 0.23
Current Fiscal Year (ends Sep 2013) 0.89 0.89 0.89 0.89 0.88
Next Fiscal Year (ends Sep 2014) 1.02 1.02 0.99 0.98 0.99

Data provided by Zacks Investment Research.

Earnings Revisions
Last 7 Days Last 30 Days
Up Revs Down Revs Up Revs Down Revs
0 0 0 2
0 0 0 2
0 0 1 1
0 0 1 1